Publicaciones en colaboración con investigadoras/es de Ruhr University Bochum (27)

2024

  1. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson’s disease study

    Brain, Vol. 147, Núm. 8, pp. 2652-2667

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. New genotype-phenotype correlations in a large European cohort of patients with sarcoglycanopathy

    Brain, Vol. 143, Núm. 9, pp. 2696-2708

  2. The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis

    Cells, Vol. 9, Núm. 1

  3. The operative management in Bariatric Acute Abdomen (OBA) survey: Long-term complications of bariatric surgery and the emergency surgeon's point of view

    World Journal of Emergency Surgery, Vol. 15, Núm. 1

2018

  1. A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study)

    European Neuropsychopharmacology, Vol. 28, Núm. 1, pp. 185-194

  2. A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson’s disease

    Expert Opinion on Pharmacotherapy, Vol. 19, Núm. 9, pp. 937-945

  3. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations

    European Journal of Heart Failure, Vol. 20, Núm. 10, pp. 1472-1481

  4. Recovery and performance in sport: Consensus statement

    International Journal of Sports Physiology and Performance, Vol. 13, Núm. 2, pp. 240-245

2017

  1. Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis

    European Respiratory Journal, Vol. 49, Núm. 2

  2. Treat-To-Target (T2T) recommendations for gout

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 4, pp. 632-638

2016

  1. Analysis of plasminogen genetic variants in multiple sclerosis patients

    G3: Genes, Genomes, Genetics, Vol. 6, Núm. 7, pp. 2073-2079

  2. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  4. Radiotherapy with 4 Gy × 5 versus 3 Gy × 10 for metastatic epidural spinal cord compression: Final results of the SCORE-2 Trial (ARO 2009/01)

    Journal of Clinical Oncology, Vol. 34, Núm. 6, pp. 597-602

2015

  1. A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis

    Human Molecular Genetics, Vol. 24, Núm. 19, pp. 5644-5654

  2. Genome-wide significant association with seven novel multiple sclerosis risk loci

    Journal of Medical Genetics, Vol. 52, Núm. 12, pp. 848-855

2014

  1. Air pollution during pregnancy and childhood cognitive and psychomotor development: Six european birth cohorts

    Epidemiology, Vol. 25, Núm. 5, pp. 636-647

2013

  1. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases

    Respiratory Medicine, Vol. 107, Núm. 9, pp. 1444-1452

  2. MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis

    Brain, Vol. 136, Núm. 6, pp. 1778-1782